Screener
Biogen BIIB Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Biogen’s reported figures.
Based on the most recent quarter.
The source filing: Biogen’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 6:36 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000875045-26-000075
FAQ
- What is Biogen's debt-to-equity?
- Biogen (BIIB) reported debt-to-equity of 0.4× in Q2 2026.
- How has Biogen's debt-to-equity changed year-over-year?
- Biogen's debt-to-equity increased by 7.2% year-over-year, from 0.4× to 0.4×.
- What is the long-term trend for Biogen's debt-to-equity?
- Over 5 years (2020 to 2025), Biogen's debt-to-equity has grown at a -13.2% compound annual growth rate (CAGR), from 0.7× to 0.4×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Biogen's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude